MARKSANS PHARMA
|
MARKSANS PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹1,549 Cr | ₹1,392 Cr | ₹1,134,208,953 Cr | ₹1,000 Cr | ₹913 Cr |
Sales | ₹1,538 Cr | ₹1,384 Cr | ₹1,129,334,892 Cr | ₹987 Cr | ₹904 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹11 Cr | ₹7.81 Cr | ₹4,874,061 Cr | ₹13 Cr | ₹8.62 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹1,491 Cr | ₹1,376 Cr | ₹1,134,208,953 Cr | ₹1,000 Cr | ₹913 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹13 Cr | ₹-136 Cr | ₹52,947,288 Cr | ₹-20 Cr | ₹21 Cr |
Raw Material Consumed | ₹704 Cr | ₹731 Cr | ₹514,884,222 Cr | ₹518 Cr | ₹503 Cr |
Opening Raw Materials | ₹118 Cr | ₹92 Cr | ₹90,175,248 Cr | ₹35 Cr | ₹190 Cr |
Purchases Raw Materials | ₹574 Cr | ₹446 Cr | ₹395,829,134 Cr | ₹467 Cr | ₹194 Cr |
Closing Raw Materials | ₹151 Cr | ₹118 Cr | ₹91,720,389 Cr | ₹90 Cr | ₹35 Cr |
Other Direct Purchases / Brought in cost | ₹163 Cr | ₹312 Cr | ₹120,600,229 Cr | ₹106 Cr | ₹154 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹19 Cr | ₹16 Cr | ₹14,378,363 Cr | ₹14 Cr | ₹12 Cr |
Electricity & Power | - | ₹16 Cr | ₹14,002,502 Cr | ₹14 Cr | ₹12 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | ₹19 Cr | ₹0.47 Cr | ₹375,861 Cr | ₹0.35 Cr | ₹0.28 Cr |
Employee Cost | ₹220 Cr | ₹197 Cr | ₹168,416,355 Cr | ₹159 Cr | ₹148 Cr |
Salaries, Wages & Bonus | ₹204 Cr | ₹180 Cr | ₹162,308,352 Cr | ₹154 Cr | ₹142 Cr |
Contributions to EPF & Pension Funds | ₹16 Cr | ₹16 Cr | ₹4,683,304 Cr | ₹4.20 Cr | ₹3.89 Cr |
Workmen and Staff Welfare Expenses | ₹0.68 Cr | ₹2.09 Cr | ₹956,300 Cr | ₹0.78 Cr | ₹1.79 Cr |
Other Employees Cost | ₹0.40 Cr | - | ₹468,399 Cr | - | - |
Other Manufacturing Expenses | ₹13 Cr | ₹127 Cr | ₹113,315,521 Cr | ₹77 Cr | ₹60 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹13 Cr | ₹10 Cr | ₹8,294,967 Cr | ₹10 Cr | ₹9.20 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | - | ₹117 Cr | ₹105,020,554 Cr | ₹67 Cr | ₹51 Cr |
General and Administration Expenses | ₹38 Cr | ₹51 Cr | ₹45,519,298 Cr | ₹51 Cr | ₹43 Cr |
Rent , Rates & Taxes | ₹7.18 Cr | ₹15 Cr | ₹12,255,556 Cr | ₹9.27 Cr | ₹8.15 Cr |
Insurance | - | ₹12 Cr | ₹8,346,628 Cr | ₹11 Cr | ₹11 Cr |
Printing and stationery | ₹0.91 Cr | ₹1.15 Cr | ₹1,079,407 Cr | ₹1.10 Cr | ₹0.93 Cr |
Professional and legal fees | ₹21 Cr | ₹17 Cr | ₹7,866,267 Cr | ₹11 Cr | ₹7.96 Cr |
Traveling and conveyance | ₹6.12 Cr | ₹2.93 Cr | ₹7,180,837 Cr | ₹6.71 Cr | ₹4.15 Cr |
Other Administration | ₹8.53 Cr | ₹5.66 Cr | ₹15,971,440 Cr | ₹19 Cr | ₹15 Cr |
Selling and Distribution Expenses | ₹119 Cr | ₹34 Cr | ₹32,151,586 Cr | ₹68 Cr | ₹49 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹119 Cr | ₹1.64 Cr | ₹1,772,135 Cr | ₹39 Cr | ₹36 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | ₹32 Cr | ₹30,379,451 Cr | ₹30 Cr | ₹13 Cr |
Miscellaneous Expenses | ₹107 Cr | ₹16 Cr | ₹344,393 Cr | ₹-0.01 Cr | ₹0.06 Cr |
Bad debts /advances written off | ₹2.63 Cr | ₹14 Cr | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | ₹0.01 Cr | - | ₹-0.01 Cr | ₹0.06 Cr |
Losson foreign exchange fluctuations | - | ₹0.97 Cr | - | - | - |
Losson sale of non-trade current investments | - | - | ₹102,702 Cr | - | - |
Other Miscellaneous Expenses | ₹104 Cr | ₹0.84 Cr | ₹241,691 Cr | - | - |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,232 Cr | ₹1,037 Cr | ₹941,957,026 Cr | ₹868 Cr | ₹834 Cr |
Operating Profit (Excl OI) | ₹259 Cr | ₹340 Cr | ₹192,251,927 Cr | ₹132 Cr | ₹78 Cr |
Other Income | ₹42 Cr | ₹6.69 Cr | ₹327,767 Cr | ₹4.62 Cr | ₹8.47 Cr |
Interest Received | ₹5.97 Cr | ₹1.16 Cr | ₹42,684 Cr | ₹0.09 Cr | ₹0.11 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | ₹0.04 Cr | ₹24,879 Cr | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹21 Cr | - | - | ₹4.23 Cr | ₹8.12 Cr |
Others | ₹15 Cr | ₹5.50 Cr | ₹260,204 Cr | ₹0.31 Cr | ₹0.25 Cr |
Operating Profit | ₹301 Cr | ₹346 Cr | ₹192,579,693 Cr | ₹137 Cr | ₹87 Cr |
Interest | ₹8.45 Cr | ₹7.99 Cr | ₹8,746,377 Cr | ₹9.66 Cr | ₹10 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹2.71 Cr | ₹4.17 Cr | ₹2,932,231 Cr | ₹3.03 Cr | ₹2.80 Cr |
Other Interest | ₹5.74 Cr | ₹3.82 Cr | ₹5,814,146 Cr | ₹6.63 Cr | ₹7.42 Cr |
PBDT | ₹292 Cr | ₹338 Cr | ₹183,833,317 Cr | ₹127 Cr | ₹77 Cr |
Depreciation | ₹45 Cr | ₹36 Cr | ₹26,661,549 Cr | ₹23 Cr | ₹27 Cr |
Profit Before Taxation & Exceptional Items | ₹248 Cr | ₹302 Cr | ₹157,171,768 Cr | ₹104 Cr | ₹50 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹248 Cr | ₹302 Cr | ₹157,171,768 Cr | ₹104 Cr | ₹50 Cr |
Provision for Tax | ₹61 Cr | ₹64 Cr | ₹36,419,083 Cr | ₹24 Cr | ₹14 Cr |
Current Income Tax | ₹57 Cr | ₹67 Cr | ₹32,405,957 Cr | ₹24 Cr | ₹13 Cr |
Deferred Tax | ₹3.59 Cr | ₹-3.07 Cr | ₹4,466,111 Cr | ₹1.01 Cr | ₹0.60 Cr |
Other taxes | ₹0.01 Cr | - | ₹-452,985 Cr | ₹-0.72 Cr | ₹0.00 Cr |
Profit After Tax | ₹187 Cr | ₹239 Cr | ₹120,752,685 Cr | ₹80 Cr | ₹36 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-2.25 Cr | ₹-2.60 Cr | ₹-3,733,409 Cr | ₹-3.98 Cr | ₹-2.86 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹185 Cr | ₹236 Cr | ₹117,019,275 Cr | ₹76 Cr | ₹33 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹335 Cr | ₹85 Cr | ₹2,978,356 Cr | ₹-69 Cr | ₹-99 Cr |
Appropriations | ₹519 Cr | ₹321 Cr | ₹119,997,631 Cr | ₹7.39 Cr | ₹-66 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹10 Cr | ₹-14 Cr | ₹29,888,488 Cr | ₹4.41 Cr | ₹2.34 Cr |
Equity Dividend % | ₹25.00 | ₹25.00 | ₹10.00 | ₹5.00 | ₹5.00 |
Earnings Per Share | ₹4.51 | ₹5.76 | ₹2.86 | ₹1.87 | ₹0.80 |
Adjusted EPS | ₹4.51 | ₹5.76 | ₹2.86 | ₹1.87 | ₹0.80 |
Compare Income Statement of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,731.6 Cr | 2% | -8.9% | 109.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹98,684.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 2% |
-8.9% |
109.1% |
SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses